Ampcare

Ampcare manufactures and distributes the Effective Swallowing Protocol (ESP), a neuromuscular electrical stimulation (NMES) system combined with resistive exercise and restorative posture devices for dysphagia (swallowing disorder) treatment. The ESP protocol targets swallow anatomy, provides airway resistance, and uses perturbation science to accelerate airway closure time, reducing aspiration risk. The system features patented electrode design with larger contact surfaces to minimize patient discomfort ("hot spots") compared to competing NMES devices. Ampcare positions cost-effectiveness as a competitive advantage, citing $1.63 per-treatment electrode cost. The company offers comprehensive speech-language pathology (SLP) training through ASHA CE-accredited certification workshops available in live classroom (4–8 hours in-person), on-demand, and hybrid formats. Training covers anatomy, physiology, muscle fiber recruitment, electrotherapy principles, and evidence supporting the ESP protocol. Ampcare targets speech-language pathologists and swallow therapy clinicians in rehabilitation and outpatient settings. The product is supported by published research demonstrating functional improvements in swallow safety and patient outcomes.